The intratumoral expression of vascular endothelial growth factor and interleukin-8 associated with angiogenesis in nonsmall cell lung carcinoma patients

Cancer

Volumn 92, Issue 10, 2001, Pages 2628-2638

  Masuya, Daiki ^a   Huang, Cheng Long ^a   Liu, Dage ^a   Kameyama, Kotaro ^a   Hayashi, Eiichi ^a   Yamauchi, Akira ^a   Kobayashi, Shoji ^a   Haba, Reiji ^a   Yokomise, Hiroyasu ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Angiogenesis; CD34; Immunohistochemistry; Interleukin 8; Lung carcinoma; Microvessel density; Prognosis; Vascular endothelial growth factor

Indexed keywords

ANGIOGENIC FACTOR; INTERLEUKIN 8; VASCULOTROPIN;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; METASTASIS; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; SURVIVAL RATE; TUMOR GROWTH;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; ENDOTHELIAL GROWTH FACTORS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-8; LUNG NEOPLASMS; LYMPHOKINES; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035889962     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20011115)92:10<2628::AID-CNCR1616>3.0.CO;2-F     Document Type: Article

References (47)

1. Proposals regarding some deficiencies in the new international staging system for non-small cell lung cancer
2. Adjuvant chemotherapy for completely resected stage III non-small-cell lung cancer
3. The implications of angiogenesis for the biology and therapy of cancer metastasis
4. What is the evidence that tumors are angiogenesis dependent?
5. Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma
6. Relation of neovascularisation to metastasis of non-small cell lung cancer
7. Association between tumor angiogenesis and tumor cell shedding into effluent venous blood during breast cancer surgery
8. Clinical applications of research on angiogenesis
9. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
10. Platelet-derived endothelial cell growth factor (thymidine phosphorylase) expression in lung cancer
11. Interleukin-8 as a macrophage-derived mediator of angiogenesis
12. The role of CXC chemokines in the regulation of angiogenesis in non-small cell lung cancer
13. Neutrophil alveolitis in bronchioloalveolar carcinoma: Induction by tumor-derived interleukin-8 and relation to clinical outcome
14. Tumor angiogenesis as a prognostic marker in operable non-small cell lung cancer
15. Prognostic significance of angiogenesis in human pancreatic cancer
16. Revisions in the international system for staging lung cancer
17. Microvessel quantitation and prognosis in invasive breast carcinoma
18. Angiogenesis in cancer, vascular, rheumatoid and other disease
19. Neoplasms of the lung
20. Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival
21. Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage
22. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth
23. Angiostatin induces and sustains dormancy of human primary tumors in mice
24. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
25. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA
26. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant
27. Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells
28. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
29. Vascular endothelial growth factor induced by hypoxia may mediate hypoxiainitiated angiogenesis
30. The human gene for vascular endothelial growth factor
31. Mutant ras oncogenes upregulate VEGF/VPF expression: Implications for induction and inhibition of tumor angiogenesis
32. Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression
33. Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma
34. Vascular endothelial growth factor and lymph node metastasis in primary lung cancer
35. Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer
36. Vascular endothelial growth factor and its receptor correlate with angiogenesis and survival in pulmonary adenocarcinoma
37. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma
38. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma
39. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma
40. Molecular cloning of a human monocytederived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor
41. Interleukin-8. A corneal factor that induces neovascularization
42. Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis
43. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer
44. Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma
45. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice
46. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis
47. Interleukin-8 participates in angiogenesis in non-small cell, but not small cell carcinoma of the lung